Since Aβ penetrates through the BBB from the blood to the brain by binding to RAGE, differences in binding with modified forms of Aβ42 can lead to a preferential transfer of one or another isoform to the brain, which is one of the AD risk factors. The gene discussed is AGER; the disease is Alzheimer disease.